News Pharmacogenomic testing pilot to start in general practice from June 2023 The pilot will test patients when they start a new statin, certain antidepressants or proton pump inhibitors to ensure they are on the right medication and not at risk of side effects.…Published: 18 May 2023
Feature Newborn genome screening: a step too far? A project to screen the genomes of 100,000 babies for rare diseases is set to begin recruiting in 2023, but it will face ethical and societal challenges.…Published: 6 January 2023
News Pharmacists should be able to refer patients to NHS genomics services, says Royal Pharmaceutical Society In the Society's consultation response, Thorrun Govind said there needs to be an explanation of how pharmacy staff can enrich and complement the NHS Clinical Genomics Service.…Published: 18 November 2022
Opinion How we set up the UK’s first clopidogrel genomics testing system Specialist clinical pharmacist Alex Matos explains how he has been implementing pharmacogenomics in daily use on the acute stroke ward.…Published: 1 August 2022
News Safety review launched into anti-epileptic medicine topiramate over fears of harm to unborn children The review was prompted by study results that showed there was a two- to four-fold increased risk of developmental disorders or learning difficulties in children exposed to topiramate before birth.…Published: 27 July 2022
News Pharmacogenomic testing may aid antidepressant prescribing, study results show Researchers found that patients with major depressive disorder whose treatment was guided by genetic testing were more likely to receive an antidepressant with no drug–gene interaction.…Published: 13 July 2022
Feature Everything you need to know about the NHS genomic medicine service A closer look at the progress made so far on NHS England’s new national genomic medicine service.…Published: 21 June 2022
Letter Help us develop an e-learning module on cell and gene therapiesCell and gene therapies are emerging types of medicines that aim to provide treatment opportunities to individuals, with application across a number of illnesses. Cell and gene therapies are types of advanced therapy medicinal products (ATMPs) that are biological medicines based on either genes,…Published: 7 March 2022
News Pharmacogenetic testing in community pharmacy could improve drug selection and cut adverse reactions, study finds Researchers have estimated that an actionable drug–gene interaction was present for around 20% of all new prescriptions for 56 common medicines.…Published: 22 January 2021
News Personalised medicine approach could benefit people with asthma Prescribing asthma treatment based on genetic differences could improve outcomes, results presented at the European Respiratory Society International Congress have suggested.…Published: 12 October 2020
